ReviewFrontiers in neurology2020
Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging.
Review in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
66 citing papers in PubMed, 119 citations in OpenAlex.
- Risk factors and long-term outcomes in smart syndrome: a multicenter study.Journal of neuro-oncology · 2026Article
- Posterior reversible encephalopathy syndrome in drug-induced syndrome of inappropriate ADH secretion: a case report.Journal of medical case reports · 2026Article
- Systemic Immune-Inflammation Index and Clinical Predictors of Atypical PRES in Eclampsia: Higher Blood Pressure and Inflammatory Burden Drive Multi-Regional Involvement.Biomedicines · 2026Article
- Posterior Reversible Encephalopathy Syndrome Following Recreational Nitrous Oxide Use: A Case Report.Cureus · 2026Article
- Posterior Reversible Encephalopathy Syndrome in Peritoneal Dialysis Patients: A Four-Case Series.Journal of clinical medicine · 2026Article
- Posterior reversible encephalopathy syndrome in dengue virus infection with concurrent encephalitis and ischemic stroke: a case report.BMC infectious diseases · 2026Article
- Posterior reversible encephalopathy syndrome (PRES): A narrative review of pathophysiology, clinical insights, and advances in management.International journal of emergency medicine · 2026Review
- Predictors of intensive care unit admission in posterior reversible encephalopathy syndrome patients with preeclampsia or eclampsia: a 10-year retrospective study.BMC pregnancy and childbirth · 2026Article
- A presentation of posterior reversible encephalopathy syndrome after heart transplantation: a case report and review of literature.Journal of medical case reports · 2025Review
- Clinico-radiological correlations in posterior reversible encephalopathy syndrome: toward a better understanding of its heterogeneous manifestations.Neuroradiology · 2025Article
- High risk and low incidence diseases: Aneurysmal subarachnoid hemorrhage.The American journal of emergency medicine · 2025Review
- Article
- Rituximab (monoclonal anti-CD20 antibody) induced posterior reversible encephalopathy syndrome (PRES): A case report and literature review.Radiology case reports · 2025Article
- Posterior reversible enzephalopathie syndrome (PRES) following vestibular schwannoma surgery - Case report and review of the current theories on pathophysiology of PRES.Brain & spine · 2025Review
- Rare complications of Crohn's disease - a series of three cases.Polish journal of radiology · 2025Review
- A novelFrontiers in genetics · 2025Article
- Anton's Syndrome Secondary to Metronidazole Toxicity.Annals of Indian Academy of Neurology · 2025Article
- Article
- Posterior Reversible Encephalopathy Syndrome with Renal Disease.Indian journal of pediatrics · 2024Article
- Magnetic resonance imaging patterns and perfusion changes of posterior reversible encephalopathy syndrome in children with clinical outcome correlation.Pediatric radiology · 2024Observational
6 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posterior reversible encephalopathy syndrome (PRES) represents a unique clinical entity with non-specific clinical symptoms and unique neuroradiological findings. This syndrome may present with a broad range of clinical symptoms from headache and visual disturbances to seizure and altered mentation. Typical imaging findings include posterior-circulation predominant vasogenic edema. Although there are many well-documented diseases associated with PRES, the exact pathophysiologic mechanism has yet to be fully elucidated. Generally accepted theories revolve around disruption of the blood-brain barrier secondary to elevated intracranial pressures or endothelial injury. In this article, we will review the clinical, typical, and atypical radiological features of PRES, as well as the most common theories behind the pathophysiology of PRES. Additionally, we will discuss some of the treatment strategies for PRES related to the underlying disease state.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.